Study assessing virological response and resistance profile in virologically suppressed HIV- 1 infected individuals switching to a bictegravir based treatment in clinical practice
Latest Information Update: 24 Dec 2021
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
Most Recent Events
- 24 Dec 2021 New trial record
- 30 Oct 2021 Results presented at the 18th European AIDS Conference